Differential expression of piRNAs in brain from patients with Alzheimer's disease

Abstract

Abstract: Objective To investigate the differential expression of piRNAs in brain tissues from patients with Alzheimer's disease (AD), and to study the roles of these piRNAs related to AD. Methods With age and sex matching, 6 AD (pathological AD) and 7 control subjects were selected. RNAs were converted into piRNAs after extracting from the prefrontal lobe brain tissues, then piRNAs were reversed transcription into cDNA. Based on preliminary results, 10 piRNAs expressed in brain tissues were selected: DQ571030, DQ597973, DQ576872, DQ597479, DQ586404, DQ590835, DQ600318, DQ581610, DQ586113 and DQ571669. The expression of piRNAs was detected by real-time PCR. Those mRNA related with piRNAs of significant differences were further studied. Results A trend of decrease was found in the expression of all the 10 piRNAs in the AD group. The expression of 4 piRNAs DQ597973, DQ576872, DQ597479 and DQ600318 were significantly decreased in the AD group(P＜0.05). The related mRNA LRRC37A3 of DQ600318 was further studied. DQ600318 showed the most significant difference in expression. The expression of LRRC37A3 was also significantly decreased in the AD group (P＜0.01). Conclusions The decreasing expression of DQ600318 and LRRC37A3 is potentially related to AD, and the detection of DQ600318 may function as a marker of AD pathogenesis.

Key words: Alzheimer's disease, piRNA, mRNA

CLC Number:

R322.81

SUN Tian-yi, LIU Fan, QIU Wen-ying, MA Chao. Differential expression of piRNAs in brain from patients with Alzheimer's disease[J]. Basic & Clinical Medicine, 2021, 41(4): 533-538.

References

[1] Yilmaz U. Alzheimer's disease[J]. Radiologe,2015,55:386-388.
[2] Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention[J]. Dialogues Clin Neurosci,2009,11:111-128.
[3] Hamilton AJ, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants[J]. Science,1999,286:950-952.
[4] Werick EM, Miska EA. piRNAs: from biogenesis to function[J]. Development,2014,141:3458-3471.
[5] Ozata DM, Gainetdinov I, Zoch A, et al. PIWI-interacting RNAs: small RNAs with big functions[J]. Nat Rev Genet,2019,20:89-108.
[6] Millan MJ. Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: an integrative review[J]. Prog Neurobiol,2017,156:1-68.
[7] Qiu W, Guo X, Lin X, et al. Transcriptome-wide piRNA profiling in human brains of Alzheimer's disease[J]. Neurobiol Aging,2017,57:170-177.
[8] Qiu W, Zhang H, Bao A, et al. Standardized operational protocol for human brain banking in China[J]. Neurosci Bull,2019,35:270-276.
[9] Thomas J, Montine, Creighton H, et al. National institute on aging-Alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach[J]. Acta Neuropathol,2012,123:1-11.
[10] Hébert SS, Wang WX, Zhu Q, et al. A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls[J]. Alzheimers Dis,2013,35:335-348.
[11] Rajasethupathy P, Antonov I, Sheridan R, et al. A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity[J]. Cell,2012,149:693-707.
[12] Grivna ST, Beyret E, Wang Z, et al. A novel class of small RNAs in mouse spermatogenic cells[J]. Genes Dev,2006,20:1709-1714.
[13] Roy J, Sarkar A, Parida S, et al. Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis[J]. Mol Biosyst,2017,13:565-576.
[14] He Y, Li C, Yang Y, et al. Meta-analysis of the rs2075650 polymorphism and risk of Alzheimer disease[J]. Aging Clin Exp Res,2016,28:805-811.
[15] Yin Y, Wang Z. ApoE and neurodegenerative diseases in aging[J]. Adv Exp Med Biol,2018,1086:77-92.